<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.jurology.com//inpress?rss=yes"><title>The Journal of Urology - Articles in Press</title><description>The Journal of Urology RSS feed: Articles in Press.    The Official Journal of the American Urological Association ( AUA ), 
and the most widely read and highly cited journal in the field,  The Journal of Urology ® 
  brings solid coverage 
of the clinically relevant content needed to stay at the forefront of the dynamic field of urology. This premier journal presents investigative 
studies on critical areas of research and practice, survey articles providing short condensations of the best and most important urology 
literature worldwide, and practice-oriented reports on significant clinical observations.

 
 
 The Journal of Urology ® 
  
covers the wide scope of urology, including 
 
 
 
 pediatric urology

 
  urologic oncology (cancer)

 
  renal transplantation


 
  male infertility

 
  calculi (urinary tract stones)

 
  female urology (urinary incontinence and pelvic outlet 
relaxation disorders) 

 
  neurourology (voiding disorders, urodynamic evaluation of patients and erectile dysfunction or impotence).

 
 
 
Members of the American Urological Association may access The Journal of Urology® online by logging in  here . Nonmember personal subscribers may register and activate your 
subscription online at  www.jurology.com . Authors and reviewers may submit 
and review manuscripts  online .   </description><link>http://www.jurology.com//inpress?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2012 Published by Elsevier Inc.  </dc:rights><prism:publicationName>The Journal of Urology</prism:publicationName><prism:issn>0022-5347</prism:issn><prism:publicationDate>2012-01-23</prism:publicationDate><prism:copyright> © 2012 Published by Elsevier Inc.  </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711054474/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711054486/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711054498/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711054504/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711054516/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711054528/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS002253471105453X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711054553/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711054577/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711055480/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711055509/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711055558/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711056503/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711056515/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711056527/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711056539/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711056540/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711056552/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711056564/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711056576/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS002253471105662X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711056631/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711056643/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711056655/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711056989/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711056990/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711057004/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711057016/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711057028/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS002253471105703X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711057041/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711057053/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711057065/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711057077/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711057089/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711057119/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711057272/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711057284/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711057296/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711058010/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711058319/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711058344/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711058356/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS002253471105837X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711058381/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711058411/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711058435/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534712000328/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS002253471200033X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jurology.com/article/PIIS0022534711054607/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.jurology.com/article/PIIS0022534711054474/abstract?rss=yes"><title>3-Dimensional Elastic Registration System of Prostate Biopsy Location by Real-Time 3-Dimensional Transrectal Ultrasound Guidance With Magnetic Resonance/Transrectal Ultrasound Image Fusion - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711054474/abstract?rss=yes</link><description>
Purpose: 
We determined the accuracy of the novel Urostation 3-dimensional transrectal ultrasound system (Koelis, La Tranche, France) for image based mapping biopsies in a prostate phantom. The system is capable of 1) registering the 3-dimensional location of each biopsy track in the 3-dimensional prostate volume data and 2) performing elastic image fusion of transrectal ultrasound with magnetic resonance imaging.

Materials and Methods: 
We used 3 CIRS-053 prostate phantoms containing 3 hypoechoic lesions to perform ultrasound guided biopsy and 3 CIRS-066 phantoms (Computerized Imaging Reference Systems, Norfolk, Virginia) containing 3 isoechoic but magnetic resonance imaging visible lesions to perform magnetic resonance fusion guided biopsy. Three targeted biopsies were done per lesion. Each biopsy tract was injected with gadolinium based magnetic resonance contrast mixed with india ink. Phantoms were then subjected to 1 mm slice magnetic resonance imaging and serial step sectioning to assess the accuracy of targeted biopsy.

Results: 
A total of 27 ultrasound guided biopsies were targeted into 9 hypoechoic lesions. All 27 biopsies (100%) successfully hit the target lesion. For hypoechoic lesions mean ± SD procedural targeting error was 1.52 ± 0.78 mm and system registration error was 0.83 mm, resulting in an overall error of 2.35 mm. Of the 27 magnetic resonance fusion biopsies 24 (84%) hit the lesion. For isoechoic lesions mean procedural targeting error was 2.09 ± 1.28 mm, resulting in an overall error of 2.92 mm.

Conclusions: 
The novel, computer assisted, 3-dimensional transrectal ultrasound biopsy localization system achieved encouraging accuracy with less than 3 mm error for targeting hypoechoic and isoechoic lesions. The ability to register actual biopsy trajectory and perform elastic magnetic resonance/ultrasound image fusion is a significant advantage for future focal therapy application.
</description><dc:title>3-Dimensional Elastic Registration System of Prostate Biopsy Location by Real-Time 3-Dimensional Transrectal Ultrasound Guidance With Magnetic Resonance/Transrectal Ultrasound Image Fusion - Corrected Proof</dc:title><dc:creator>Osamu Ukimura, Mihir M. Desai, Suzanne Palmer, Samuel Valencerina, Mitchell Gross, Andre L. Abreu, Monish Aron, Inderbir S. Gill</dc:creator><dc:identifier>10.1016/j.juro.2011.10.124</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>INVESTIGATIVE UROLOGY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711054486/abstract?rss=yes"><title>Association of Randall Plaque With Collagen Fibers and Membrane Vesicles - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711054486/abstract?rss=yes</link><description>
Purpose: 
Idiopathic calcium oxalate kidney stones develop by calcium oxalate crystal deposition on Randall plaque. The mechanisms involved in Randall plaque formation are still unclear. We hypothesized that Randall plaque formation is similar to that of vascular calcification, involving components of extracellular matrix, including membrane bound vesicles and collagen fibers. To verify our hypothesis we critically examined renal papillary tissue from patients with stones.

Materials and Methods: 
We performed 4 mm cold cup biopsy of renal papillae on 15 patients with idiopathic stones undergoing percutaneous nephrolithotomy. Tissue was immediately fixed and processed for analysis by various light and electron microscopic techniques.

Results: 
Spherulitic calcium phosphate crystals, the hallmark of Randall plaque, were seen in all samples examined, including in interstitium and laminated basement membrane of tubular epithelium. Large crystalline deposits were composed of dark elongated strands mixed with spherulites. Strands showed banded patterns similar to collagen. Crystal deposits were surrounded by collagen fibers and membrane bound vesicles. Energy dispersive x-ray microanalysis and electron diffraction identified the crystals as hydroxyapatite. Few kidneys were examined and urinary data were not available on all patients.

Conclusions: 
Results showed that crystals in Randall plaque are associated with collagen and membrane bound vesicles. Collagen fibers appeared calcified and vesicles contained crystals. Crystal deposition in renal papillae may have started with membrane vesicle induced nucleation and grown by the further addition of crystals at the periphery in a collagen framework.
</description><dc:title>Association of Randall Plaque With Collagen Fibers and Membrane Vesicles - Corrected Proof</dc:title><dc:creator>Saeed R. Khan, Douglas E. Rodriguez, Laurie B. Gower, Manoj Monga</dc:creator><dc:identifier>10.1016/j.juro.2011.10.125</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>INVESTIGATIVE UROLOGY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711054498/abstract?rss=yes"><title>A Novel Therapeutic Vaccine of Mouse GM-CSF Surface Modified MB49 Cells Against Metastatic Bladder Cancer - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711054498/abstract?rss=yes</link><description>
Purpose: 
Immunotherapy is considered effective for muscle invasive bladder cancer mini metastasis. We developed what is to our knowledge a novel technology by which streptavidin tagged mouse GM-CSF was displayed on the surface of biotinylated bladder cancer cells to induce antitumor immunity.

Materials and Methods: 
Mouse subcutaneous and lung metastasis bladder cancer models were established. Mice were injected subcutaneously with 1 × 106 mouse GM-CSF surface modified MB49 bladder cancer cells and monitored for tumor growth and survival. Immunohistochemical and flow cytometric assay were done to assess the proportion of T lymphocytes. The T-lymphocyte cytotoxicity assay was performed to assess MB49 specific cytotoxicity. On day 60 after MB49 implantation the vaccine cured mice were injected subcutaneously with MB49 or RM-1 cells in the left or right hind leg, respectively. They were monitored for survival and T-lymphocyte cytotoxicity.

Results: 
Mouse GM-CSF surface modified vaccine significantly inhibited tumor growth in the subcutaneous model and extended survival in the lung model. More CD4 and CD8 T cells appeared at tumor sites and in peripheral blood in the vaccine treated group than in other control groups. Splenocytes from the vaccine treated group showed the most potent cytotoxicity on MB49 cells. Cured mice in the vaccine treated group resisted the second injection of MB49 bladder cancer cells but not the RM-1 prostate cancer cell challenge.

Conclusions: 
Mouse GM-CSF surface modified MB49 bladder cancer cell vaccine induced specific antitumor immunity and was efficient for metastatic bladder cancer.
</description><dc:title>A Novel Therapeutic Vaccine of Mouse GM-CSF Surface Modified MB49 Cells Against Metastatic Bladder Cancer - Corrected Proof</dc:title><dc:creator>Xinji Zhang, Xiaojun Shi, Jinlong Li, Zhiming Hu, Dong Zhou, Jimin Gao, Wanlong Tan</dc:creator><dc:identifier>10.1016/j.juro.2011.10.126</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>INVESTIGATIVE UROLOGY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711054504/abstract?rss=yes"><title>Composite Urinary Reservoir in Dogs: Histological Findings - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711054504/abstract?rss=yes</link><description>
Purpose: 
This animal study was designed to investigate whether the composite urinary reservoir might lessen the premalignant histological alterations observed after bladder augmentation performed with a gastric segment or large bowel.

Materials and Methods: 
Composite urinary reservoirs were created using gastric and colonic segments simultaneously in 8, 3-month-old female beagle dogs by augmenting half the native bladder. Two dogs with gastrocystoplasty and 2 with colocystoplasty served as controls. Biopsies were taken from the native bladder, and the gastric and colonic segments at augmentation, and endoscopically 4 and 8 months postoperatively. The dogs were sacrificed and open biopsied 12 months postoperatively. Tissue specimens were examined with routine hematoxylin and eosin, reaction and immunohistological staining for PCNA.

Results: 
At the creation of composite reservoir and gastrocoloplasty or colocystoplasty all specimens showed normal histology. At 12 months postoperatively dysplasia was found in 1 gastric segment, 2 native bladders and 3 colonic segments in the composite reservoir group. There was a single carcinoma in situ in 1 gastric segment in the composite reservoir group. In the control groups 1 colonic segment and 1 native bladder dysplasia were detected at the end of 12-month followup. There was an in situ carcinoma in 1 gastric segment in the composite reservoir.

Conclusions: 
A composite reservoir did not decrease premalignant changes in dogs during 12 months of followup. Laboratory investigations, molecular studies and longer followup are needed to approach the question of early malignant alterations after augmentation cystoplasty in animals and patients.
</description><dc:title>Composite Urinary Reservoir in Dogs: Histological Findings - Corrected Proof</dc:title><dc:creator>Zoltan Farkas Kispal, Peter Vajda, Laszlo Kereskai, Csaba S. Jakab, Attila M. Vastyan, Zsolt Juhasz, Andrew B. Pinter</dc:creator><dc:identifier>10.1016/j.juro.2011.10.127</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>INVESTIGATIVE UROLOGY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711054516/abstract?rss=yes"><title>Effect of Chemical Stimulation of the Medial Frontal Lobe on the Micturition Reflex in Rats - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711054516/abstract?rss=yes</link><description>
Purpose: 
We assessed the influence of the medial frontal lobe on micturition after chemical stimulation. We also examined the relation between the medial frontal lobe and the rostral pontine reticular formation, which has a strong inhibitory effect on micturition.

Materials and Methods: 
A total of 35 female rats underwent continuous cystometry. Bladder activity changes were examined after physiological saline, glutamate, the glutamate receptor antagonist MK-801, noradrenaline or the adrenergic α-1 receptor antagonist naftopidil was injected in the medial frontal lobe. When glutamate was injected in the medial frontal lobe, MK-801 was also injected in the rostral pontine reticular formation.

Results: 
Glutamate injection in the medial frontal lobe prolonged the interval between bladder contractions while injection of the glutamate antagonist MK-801 shortened the interval. Glutamate injection in the medial frontal lobe just after MK-801 injection in the ipsilateral rostral pontine reticular formation also prolonged the interval between bladder contractions. However, after prior injection of MK-801 in the bilateral rostral pontine reticular formation glutamate injection in the medial frontal lobe did not influence cystometric parameters. Noradrenaline injection in the medial frontal lobe shortened the interval between bladder contractions while injection of its antagonist naftopidil prolonged the interval.

Conclusions: 
Medial frontal lobe neurons excited by glutamate inhibited the micturition reflex via activation of the rostral pontine reticular formation by glutamatergic projection while medial frontal lobe neurons excited by noradrenaline facilitated the micturition reflex. Thus, the medial frontal lobe may be an important integration center for the initiation of micturition and urine storage mechanisms.
</description><dc:title>Effect of Chemical Stimulation of the Medial Frontal Lobe on the Micturition Reflex in Rats - Corrected Proof</dc:title><dc:creator>Saori Nishijima, Kimio Sugaya, Katsumi Kadekawa, Katsuhiro Ashitomi, Hideyuki Yamamoto</dc:creator><dc:identifier>10.1016/j.juro.2011.10.128</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>INVESTIGATIVE UROLOGY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711054528/abstract?rss=yes"><title>Effects of Pseudomonas Aeruginosa Virulence Factor Pyocyanin on Human Urothelial Cell Function and Viability - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711054528/abstract?rss=yes</link><description>
Purpose: 
We determined the effects of Pseudomonas aeruginosa virulence factor pyocyanin on human urothelial cell viability and function in vitro.

Materials and Methods: 
RT4 urothelial cells were treated with pyocyanin (1 to 100 μM) for 24 hours. After exposure the treatment effects were measured according to certain end points, including changes in urothelial cell viability, reactive oxygen species formation, caspase-3 activity, basal and stimulated adenosine triphosphate release, SA-β-gal activity and detection of acidic vesicular organelles.

Results: 
The 24-hour pyocyanin treatment resulted in a concentration dependent decrease in cell viability at concentrations of 25 μM or greater, and increases in reactive oxygen species formation and caspase-3 activity at 25 μM or greater. Basal adenosine triphosphate release was significantly decreased at all tested pyocyanin concentrations while stimulated adenosine triphosphate release was significantly inhibited at pyocyanin concentrations of 12.5 μM or greater with no significant stimulated release at 100 μM. Pyocyanin treated RT4 cells showed morphological characteristics associated with cellular senescence, including SA-β-gal expression. This effect was not evident at 100 μM pyocyanin and may have been due to apoptotic cell death, as indicated by increased caspase-3 activity. An increase in acridine orange stained vesicular-like organelles was observed in RT4 urothelial cells after pyocyanin treatment.

Conclusions: 
Exposure to pyocyanin alters urothelial cell viability, reactive oxygen species production and caspase-3 activity. Treatment also results in cellular senescence, which may affect the ability of urothelium to repair during infection. The virulence factor depressed stimulated adenosine triphosphate release, which to our knowledge is a novel finding with implications for awareness of bladder filling in patients with P. aeruginosa urinary tract infection.
</description><dc:title>Effects of Pseudomonas Aeruginosa Virulence Factor Pyocyanin on Human Urothelial Cell Function and Viability - Corrected Proof</dc:title><dc:creator>Catherine McDermott, Russ Chess-Williams, Gary D. Grant, Anthony V. Perkins, Amelia J. McFarland, Andrew K. Davey, Shailendra Anoopkumar-Dukie</dc:creator><dc:identifier>10.1016/j.juro.2011.10.129</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>INVESTIGATIVE UROLOGY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS002253471105453X/abstract?rss=yes"><title>Effect of OnabotulinumtoxinA on Intramural Parasympathetic Ganglia: An Experimental Study in the Guinea Pig Bladder - Corrected Proof</title><link>http://www.jurology.com/article/PIIS002253471105453X/abstract?rss=yes</link><description>
Purpose: 
We investigated whether onabotulinumtoxinA injected in the bladder would affect preganglionic parasympathetic nerve endings in intramural ganglia.

Materials and Methods: 
Guinea pig bladders were injected with 5 U of botulinum toxin. At 24 hours bladders were collected and processed for immunohistochemistry using tyrosine hydroxylase, and intact and cleaved SNAP-25. To identify the different populations of affected fibers coursing the ganglia we performed double immunoreactions for cleaved SNAP-25 and VAChT, TH or CGRP.

Results: 
VAChT immunoreactive fibers were identified in axons and varicosities of presynaptic to postganglionic parasympathetic neurons. Those fibers were also immunoreactive to SV2 and SNAP-25. The rare CGRP and TH immunoreactive fibers coursing in the ganglia did not express SV2 or SNAP-25. After onabotulinumtoxinA injection the cleaved form of SNAP-25 was abundantly expressed in parasympathetic fibers.

Conclusions: 
Botulinum toxin injection in the bladder wall affects preganglionic parasympathetic nerve terminals. This could contribute to the strong effect of botulinum toxin on bladder smooth muscle activity.
</description><dc:title>Effect of OnabotulinumtoxinA on Intramural Parasympathetic Ganglia: An Experimental Study in the Guinea Pig Bladder - Corrected Proof</dc:title><dc:creator>Ana Coelho, Francisco Cruz, Célia D. Cruz, António Avelino</dc:creator><dc:identifier>10.1016/j.juro.2011.10.130</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>INVESTIGATIVE UROLOGY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711054553/abstract?rss=yes"><title>Introducing a Large Animal Model to Create Urethral Stricture Similar to Human Stricture Disease: A Comparative Experimental Microscopic Study - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711054553/abstract?rss=yes</link><description>
Purpose: 
In this tissue engineering study we investigated urethral stricture formation to evaluate different treatment modalities in the large animal model and validate the most current, comparable effect of human stricture development for successful human clinical application.

Materials and Methods: 
In 12 male minipigs stricture formation was evaluated by urethrography 1, 8 and 12 weeks after stricture induction by ligation, urethrotomy or thermocoagulation. Normal human urethral and scar tissue of 6 patients was harvested and compared to animal specimens. The effect of urethral damage was investigated for microvessel density and collagen I:III ratio.

Results: 
A week after urethrotomy urothelium covered the spongiosum tissue, showing minimal infiltration of lymphocytes and macrophages, and sporadic eosinophil granulocytes. However, increased connective tissue was observed with time as well as urethral luminal narrowing, vascular network loss (decreased microvessel density) and significantly increased collagen with a favorably revised collagen type I:III ratio. The 3 methods of stricture induction resulted in different stricture severity in the animal model (thermocoagulation &gt;ligation &gt;urethrotomy). Porcine urethral samples after thermocoagulation showed a significantly increased collagen I:III ratio (p &lt;0.001), almost equal to that of human urethral stricture specimens.

Conclusions: 
We successfully developed a large animal model in which to study urethral stricture formation by defined iatrogenic intervention. The established animal model advances investigation to evaluate new therapy modalities in a preclinical setting to treat urethral stricture and predict clinical outcome.
</description><dc:title>Introducing a Large Animal Model to Create Urethral Stricture Similar to Human Stricture Disease: A Comparative Experimental Microscopic Study - Corrected Proof</dc:title><dc:creator>Karl-Dietrich Sievert, Christian Selent-Stier, J. Wiedemann, T.-O. Greiner, Bastian Amend, A. Stenzl, Gerhardt Feil, J. Seibold</dc:creator><dc:identifier>10.1016/j.juro.2011.10.132</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>INVESTIGATIVE UROLOGY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711054577/abstract?rss=yes"><title>A Brief History of Rejuvenation Operations - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711054577/abstract?rss=yes</link><description>
Purpose: 
We discuss the place in history of operative procedures for hormonal rejuvenation.

Materials and Methods: 
The scientific and historical literature was reviewed.

Results: 
In the early 20th century, building on the earlier work of Berthold and Brown-Séquard, Eugen Steinach developed a combination of vasectomy and vasoligature that became known as the Steinach operation. This procedure, along with testicular implantation popularized by Serge Voronoff, was an attempt to rejuvenate older and fatigued men around the world. The early experiments and results of Steinach, Voronoff and their followers were plagued by secrecy, subjectivity and sensationalism in an effort to produce the most scientific data. These rejuvenists used their results to outcompete one another. Ultimately the lack of verifiable outcome data and the chemical isolation of the “internal secretion” (testosterone) ended this era in surgery.

Conclusions: 
Always a work in progress, the practice of medicine has been guided by human curiosity with trial, error and success. History records aberrant paths along the way and the rejuvenation movement was one such journey. While superseded by later knowledge, the efforts of the rejuvenists comprise an interesting chapter in the development of urology, endocrinology and transplant surgery.
</description><dc:title>A Brief History of Rejuvenation Operations - Corrected Proof</dc:title><dc:creator>Michael A. Kozminski, David A. Bloom</dc:creator><dc:identifier>10.1016/j.juro.2011.10.134</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>HISTORICAL ARTICLE</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711055480/abstract?rss=yes"><title>Re: Hydrodissection of Neurovascular Bundles During Open Radical Prostatectomy Improves Postoperative Potency: M. I. Patel, D. Spernat and E. Lopez-CoronaJ Urol 2011; 186: 233–237 - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711055480/abstract?rss=yes</link><description>The authors describe the use of a hydrodissection technique during radical retropubic prostatectomy to minimize surgical damage to neurovascular bundles and to obtain better restoration of postoperative potency. In this regard, we already presented our preliminary results with a hydrodissection technique for neurovascular bundle preservation during retropubic radical prostatectomy in 35 selected patients studied between January 2006 and March 2007. In our experience hydrodissection (especially when performed with loupe magnification) permits better recognition of the prostatic fascia and the thin “Aphrodite veil,” and improves neurovascular bundle preservation with minimal bleeding. In carefully selected patients we also performed radical retropubic prostatectomy with seminal vesicle preservation, obtaining further improvement of functional results without increasing oncologic risk. Further randomized studies are needed to investigate whether hydrodissection, even if anatomically intriguing, is really useful compared to the nerve sparing technique previously described by Walsh.</description><dc:title>Re: Hydrodissection of Neurovascular Bundles During Open Radical Prostatectomy Improves Postoperative Potency: M. I. Patel, D. Spernat and E. Lopez-CoronaJ Urol 2011; 186: 233–237 - Corrected Proof</dc:title><dc:creator>Marizio Bellina, Mauro Mari, Alessandra Ambu, Francesco Mangione</dc:creator><dc:identifier>10.1016/j.juro.2011.10.163</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>LETTERS TO THE EDITOR/ERRATA</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711055509/abstract?rss=yes"><title>Re: Familial Testicular Torsion: J. Cubillos, J. S. Palmer, S. C. Friedman, J. Freyle, F. C. Lowe and L. S. PalmerJ Urol, suppl, 2011; 185: 2469–2472 - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711055509/abstract?rss=yes</link><description>The authors make an important contribution to the literature with a prospective study of the prevalence of familial testicular torsion among all patients with testicular torsion. The article certainly is an eye-opener.</description><dc:title>Re: Familial Testicular Torsion: J. Cubillos, J. S. Palmer, S. C. Friedman, J. Freyle, F. C. Lowe and L. S. PalmerJ Urol, suppl, 2011; 185: 2469–2472 - Corrected Proof</dc:title><dc:creator>Alex Shteynshlyuger</dc:creator><dc:identifier>10.1016/j.juro.2011.10.165</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>LETTERS TO THE EDITOR/ERRATA</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711055558/abstract?rss=yes"><title>Attenuation of Spermatogonial Stem Cell Activity in Cryptorchid Testes - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711055558/abstract?rss=yes</link><description>
Purpose: 
To elucidate the mechanism of infertility caused by cryptorchidism we focused on early stage spermatogenesis and spermatogonial stem cell activity in undifferentiated spermatogonia in cryptorchid testes.

Materials and Methods: 
Histological findings and expression patterns of the stem cell marker undifferentiated embryonic cell transcription factor 1 were examined in a unilateral cryptorchid rat model. We removed unilateral descended testis and contralateral descended testis from cryptorchid and normal rats (control), respectively, 18 days postcoitum to 144 days postpartum.

Results: 
In descended testes gonocyte differentiation into early A spermatogonia occurred at 9 days postpartum. However, this transformation was altered in undescended testes. Furthermore, the undifferentiated embryonic cell transcription factor 1 negative early A spermatogonia-to-positive early A spermatogonia ratio was significantly higher in the undescended testis group (mean ± SD 0.69 ± 0.04) than in the control (0.46 ± 0.10, p = 0.037) and descended testis (0.44 ± 0.05, p = 0.022) groups, indicating decreased early A spermatogonia with spermatogonial stem cell activity in cryptorchid testes.

Conclusions: 
In cryptorchid testes the differentiation from gonocytes into early A spermatogonia and the stem cell activity of early A spermatogonia were altered during the early stage of spermatogenesis, suggesting that the loss of spermatogonial stem cell activity in cryptorchid rats resulted in altered spermatogenesis, thus interfering with fertility.
</description><dc:title>Attenuation of Spermatogonial Stem Cell Activity in Cryptorchid Testes - Corrected Proof</dc:title><dc:creator>Hideyuki Kamisawa, Yoshiyuki Kojima, Kentaro Mizuno, Makoto Imura, Yutaro Hayashi, Kenjiro Kohri</dc:creator><dc:identifier>10.1016/j.juro.2011.10.170</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>PEDIATRIC UROLOGY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711056503/abstract?rss=yes"><title>Re: Epigenetic Regulation of Phosphatidylinositol 3,4,5-Triphosphate-Dependent Rac Exchanger 1 Gene Expression in Prostate Cancer Cells - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711056503/abstract?rss=yes</link><description>C. Y. Wong, H. Wuriyanghan, Y. Xie, M. F. Lin, P. W. Abel and Y. Tu   Department of Pharmacology, Creighton University School of Medicine, Omaha, Nebraska</description><dc:title>Re: Epigenetic Regulation of Phosphatidylinositol 3,4,5-Triphosphate-Dependent Rac Exchanger 1 Gene Expression in Prostate Cancer Cells - Corrected Proof</dc:title><dc:creator>Anthony Atala</dc:creator><dc:identifier>10.1016/j.juro.2011.11.022</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711056515/abstract?rss=yes"><title>Re: Targeting the Regulation of Androgen Receptor Signaling by the Heat Shock Protein 90 Cochaperone FKBP52 in Prostate Cancer Cells - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711056515/abstract?rss=yes</link><description>J. T. De Leon, A. Iwai, C. Feau, Y. Garcia, H. A. Balsiger, C. L. Storer, R. M. Suro, K. M. Garza, S. Lee, Y. S. Kim, Y. Chen, Y. M. Ning, D. L. Riggs, R. J. Fletterick, R. K. Guy, J. B. Trepel, L. M. Neckers and M. B. Cox</description><dc:title>Re: Targeting the Regulation of Androgen Receptor Signaling by the Heat Shock Protein 90 Cochaperone FKBP52 in Prostate Cancer Cells - Corrected Proof</dc:title><dc:creator>Anthony Atala</dc:creator><dc:identifier>10.1016/j.juro.2011.11.023</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711056527/abstract?rss=yes"><title>Re: IGFBP-3 is a Metastasis Suppression Gene in Prostate Cancer - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711056527/abstract?rss=yes</link><description>H. H. Mehta, Q. Gao, C. Galet, V. Paharkova, J. Wan, J. Said, J. J. Sohn, G. Lawson, P. Cohen, L. J. Cobb and K. W. Lee   Mattel Children's Hospital UCLA, Los Angeles, California</description><dc:title>Re: IGFBP-3 is a Metastasis Suppression Gene in Prostate Cancer - Corrected Proof</dc:title><dc:creator>Anthony Atala</dc:creator><dc:identifier>10.1016/j.juro.2011.11.024</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711056539/abstract?rss=yes"><title>Re: Modified Hospital Elder Life Program: Effects on Abdominal Surgery Patients - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711056539/abstract?rss=yes</link><description>C. C.-H. Chen, M.-T. Lin, Y.-W. Tien, C.-J. Yen, G.-H. Huang and S. K. Inouye   Department of Nursing, National Taiwan University College of Medicine, National Taiwan University Hospital, Taipei, Taiwan</description><dc:title>Re: Modified Hospital Elder Life Program: Effects on Abdominal Surgery Patients - Corrected Proof</dc:title><dc:creator>Richard K. Babayan</dc:creator><dc:identifier>10.1016/j.juro.2011.11.025</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711056540/abstract?rss=yes"><title>Re: Laparoendoscopic Single-Site (LESS) Surgery Versus Conventional Laparoscopic Surgery: Comparison of Surgical Port Performance in a Surgical Simulator With Novices - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711056540/abstract?rss=yes</link><description>B. Brown-Clerk, A. E. de Laveaga, C. A. LaGrange, L. M. Wirth, B. R. Lowndes and M. S. Hallbeck   Department of Industrial and Management Systems Engineering, University of Nebraska-Lincoln, Lincoln, Nebraska</description><dc:title>Re: Laparoendoscopic Single-Site (LESS) Surgery Versus Conventional Laparoscopic Surgery: Comparison of Surgical Port Performance in a Surgical Simulator With Novices - Corrected Proof</dc:title><dc:creator>Jeffrey A. Cadeddu</dc:creator><dc:identifier>10.1016/j.juro.2011.11.026</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711056552/abstract?rss=yes"><title>Re: A Randomized Prospective Study of Single-Port and Four-Port Approaches for Hysterectomy in Terms of Postoperative Pain - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711056552/abstract?rss=yes</link><description>Y. W. Jung, M. Lee, G. W. Yim, S. H. Lee, J. H. Paek, H. Y. Kwon, E. J. Nam, S. W. Kim and Y. T. Kim   Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea</description><dc:title>Re: A Randomized Prospective Study of Single-Port and Four-Port Approaches for Hysterectomy in Terms of Postoperative Pain - Corrected Proof</dc:title><dc:creator>Jeffrey A. Cadeddu</dc:creator><dc:identifier>10.1016/j.juro.2011.11.027</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711056564/abstract?rss=yes"><title>Re: What Can We Learn From Pediatric Urology Certification Logs? - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711056564/abstract?rss=yes</link><description>B. A. Kogan and P. J. Feustel   Division of Urology, Department of Surgery, Albany Medical College, Albany, New York</description><dc:title>Re: What Can We Learn From Pediatric Urology Certification Logs? - Corrected Proof</dc:title><dc:creator>Douglas A. Canning</dc:creator><dc:identifier>10.1016/j.juro.2011.11.028</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711056576/abstract?rss=yes"><title>Re: Evaluation of the United States Pediatric Urology Workforce and Fellowships: A Series of Surveys Performed in 2006–2010 - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711056576/abstract?rss=yes</link><description>D. A. Husmann, J. C. Routh, J. A. Hagerty, G. M. Cannon, P. Gomez, E. Y. Cheng and S. Skoog   Department of Urology, Mayo Clinic, Rochester, Minnesota</description><dc:title>Re: Evaluation of the United States Pediatric Urology Workforce and Fellowships: A Series of Surveys Performed in 2006–2010 - Corrected Proof</dc:title><dc:creator>Douglas A. Canning</dc:creator><dc:identifier>10.1016/j.juro.2011.11.029</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS002253471105662X/abstract?rss=yes"><title>Re: Does Better Quality of Care for Falls and Urinary Incontinence Result in Better Participant-Reported Outcomes? - Corrected Proof</title><link>http://www.jurology.com/article/PIIS002253471105662X/abstract?rss=yes</link><description>L. C. Min, D. B. Reuben, J. Adams, P. G. Shekelle, D. A. Ganz, C. P. Roth and N. S. Wenger   Division of Geriatrics, University of Michigan Medical School, Ann Arbor, Michigan</description><dc:title>Re: Does Better Quality of Care for Falls and Urinary Incontinence Result in Better Participant-Reported Outcomes? - Corrected Proof</dc:title><dc:creator>Tomas L. Griebling</dc:creator><dc:identifier>10.1016/j.juro.2011.11.034</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711056631/abstract?rss=yes"><title>Re: Prevalence and Effect on Health-Related Quality of Life of Overactive Bladder in Older Americans: Results From the Epidemiology of Lower Urinary Tract Symptoms Study - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711056631/abstract?rss=yes</link><description>C. C. Sexton, K. S. Coyne, C. Thompson, T. Bavendam, C. I. Chen and A. Markland   Center for Health Outcomes Research, United BioSource Corp., Bethesda, Maryland</description><dc:title>Re: Prevalence and Effect on Health-Related Quality of Life of Overactive Bladder in Older Americans: Results From the Epidemiology of Lower Urinary Tract Symptoms Study - Corrected Proof</dc:title><dc:creator>Tomas L. Griebling</dc:creator><dc:identifier>10.1016/j.juro.2011.11.035</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711056643/abstract?rss=yes"><title>Re: Comparison of a New Length Measurement Technique for Inflatable Penile Prosthesis Implantation to Standard Techniques: Outcomes and Patient Satisfaction - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711056643/abstract?rss=yes</link><description>G. Henry, L. Houghton, D. Culkin, J. Otheguy, R. Shabsigh and D. A. Ohl   Department of Urology, Regional Urology, Shreveport, Louisiana</description><dc:title>Re: Comparison of a New Length Measurement Technique for Inflatable Penile Prosthesis Implantation to Standard Techniques: Outcomes and Patient Satisfaction - Corrected Proof</dc:title><dc:creator>Allen F. Morey</dc:creator><dc:identifier>10.1016/j.juro.2011.11.036</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711056655/abstract?rss=yes"><title>Re: Penile Fracture: Long-Term Results of Surgical and Conservative Management - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711056655/abstract?rss=yes</link><description>W. M. Gamal, M. M. Osman, A. Hammady, M. Z. Aldahshoury, M. M. Hussein and M. Saleem   Department of Urology, Sohag University, Sohag, Egypt</description><dc:title>Re: Penile Fracture: Long-Term Results of Surgical and Conservative Management - Corrected Proof</dc:title><dc:creator>Allen F. Morey</dc:creator><dc:identifier>10.1016/j.juro.2011.11.037</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711056989/abstract?rss=yes"><title>Re: Major Depression Drives Severity of American Urological Association Symptom Index - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711056989/abstract?rss=yes</link><description>T. V. Johnson, A. Abbasi, S. S. Ehrlich, R. S. Kleris, S. L. Chirumamilla, E. D. Schoenberg, A. Owen-Smith, C. L. Raison and V. A. Master   Department of Urology, Emory University School of Medicine, Atlanta, Georgia</description><dc:title>Re: Major Depression Drives Severity of American Urological Association Symptom Index - Corrected Proof</dc:title><dc:creator>Steven A. Kaplan</dc:creator><dc:identifier>10.1016/j.juro.2011.11.041</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711056990/abstract?rss=yes"><title>Re: Nocturic Episodes in Patients With Benign Prostatic Enlargement May Suggest the Presence of Obstructive Sleep Apnea - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711056990/abstract?rss=yes</link><description>H. Tandeter, S. Gendler, J. Dreiher and A. Tarasiuk   Department of Family Medicine, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel</description><dc:title>Re: Nocturic Episodes in Patients With Benign Prostatic Enlargement May Suggest the Presence of Obstructive Sleep Apnea - Corrected Proof</dc:title><dc:creator>Steven A. Kaplan</dc:creator><dc:identifier>10.1016/j.juro.2011.11.042</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711057004/abstract?rss=yes"><title>Re: Increased Risk of Benign Prostatic Enlargement Among Patients With Liver Cirrhosis: A Nationwide Population-Based Study - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711057004/abstract?rss=yes</link><description>S. D. Chung and H. C. Lin   Division of Urology, Department of Surgery, Far Eastern Memorial Hospital, Ban Ciao and Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan</description><dc:title>Re: Increased Risk of Benign Prostatic Enlargement Among Patients With Liver Cirrhosis: A Nationwide Population-Based Study - Corrected Proof</dc:title><dc:creator>Steven A. Kaplan</dc:creator><dc:identifier>10.1016/j.juro.2011.11.043</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711057016/abstract?rss=yes"><title>Re: In Vitro Propagation of Human Prepubertal Spermatogonial Stem Cells - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711057016/abstract?rss=yes</link><description>H. Sadri-Ardekani, M. A. Akhondi, F. van der Veen, S. Repping and A. M. van Pelt   Center for Reproductive Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands</description><dc:title>Re: In Vitro Propagation of Human Prepubertal Spermatogonial Stem Cells - Corrected Proof</dc:title><dc:creator>Craig Niederberger</dc:creator><dc:identifier>10.1016/j.juro.2011.11.044</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711057028/abstract?rss=yes"><title>Re: In Situ Visualization of Damaged DNA in Human Sperm by Raman Microspectroscopy - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711057028/abstract?rss=yes</link><description>C. Mallidis, J. Wistuba, B. Bleisteiner, O. S. Damm, P. Gross, F. Wübbeling, C. Fallnich, M. Burger and S. Schlatt   Centre for Reproductive Medicine and Andrology, University of Münster, Münster, Germany</description><dc:title>Re: In Situ Visualization of Damaged DNA in Human Sperm by Raman Microspectroscopy - Corrected Proof</dc:title><dc:creator>Craig Niederberger</dc:creator><dc:identifier>10.1016/j.juro.2011.11.045</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS002253471105703X/abstract?rss=yes"><title>Re: Antisperm Antibodies are Not Associated With Pregnancy Rates After IVF and ICSI: Systematic Review and Meta-Analysis - Corrected Proof</title><link>http://www.jurology.com/article/PIIS002253471105703X/abstract?rss=yes</link><description>A. Zini, N. Fahmy, E. Belzile, A. Ciampi, N. Al-Hathal and A. Kotb   Division of Urology, Department of Surgery, McGill University, Montreal, Quebec, Canada</description><dc:title>Re: Antisperm Antibodies are Not Associated With Pregnancy Rates After IVF and ICSI: Systematic Review and Meta-Analysis - Corrected Proof</dc:title><dc:creator>Craig Niederberger</dc:creator><dc:identifier>10.1016/j.juro.2011.11.046</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711057041/abstract?rss=yes"><title>Re: Maternal Folic Acid Supplement Intake and Semen Quality in Danish Sons: A Follow-Up Study - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711057041/abstract?rss=yes</link><description>K. Jacobsen, C. H. Ramlau-Hansen, A. M. Thulstrup, J. Olsen and J. P. Bonde   Department of Occupational and Environmental Medicine, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark</description><dc:title>Re: Maternal Folic Acid Supplement Intake and Semen Quality in Danish Sons: A Follow-Up Study - Corrected Proof</dc:title><dc:creator>Craig Niederberger</dc:creator><dc:identifier>10.1016/j.juro.2011.11.047</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711057053/abstract?rss=yes"><title>Re: National Semen Analysis Reference Range Reporting: Adherence to the 1999 World Health Organization Guidelines 10 Years Later - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711057053/abstract?rss=yes</link><description>H. A. Penn, A. Windsperger, Z. Smith, S. J. Parekattil, W. W. Kuang, P. N. Kolettis and A. K. Nangia   Department of Urology, University of Kansas Medical Center, Kansas City, Kansas</description><dc:title>Re: National Semen Analysis Reference Range Reporting: Adherence to the 1999 World Health Organization Guidelines 10 Years Later - Corrected Proof</dc:title><dc:creator>Craig Niederberger</dc:creator><dc:identifier>10.1016/j.juro.2011.11.048</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711057065/abstract?rss=yes"><title>Re: How Well Informed are Women Who Undergo Urodynamic Testing? - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711057065/abstract?rss=yes</link><description>E. G. Neustaedter, J. Milne, K. Shorten, B. Weckman, A. Tse and S. Tange   Pelvic Floor Clinic, Women's Health Center, Foothills Medical Centre, Calgary, Alberta, Canada</description><dc:title>Re: How Well Informed are Women Who Undergo Urodynamic Testing? - Corrected Proof</dc:title><dc:creator>David F. Penson</dc:creator><dc:identifier>10.1016/j.juro.2011.11.049</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711057077/abstract?rss=yes"><title>Re: Physician Documentation of Fluoroscopy Time in Voiding Cystourethrography Reports Correlates With Lower Fluoroscopy Times: A Surrogate Marker of Patient Radiation Exposure - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711057077/abstract?rss=yes</link><description>S. Darling, M. Sammer, T. Chapman and M. T. Parisi   Department of Radiology, University of Washington, Seattle, Washington</description><dc:title>Re: Physician Documentation of Fluoroscopy Time in Voiding Cystourethrography Reports Correlates With Lower Fluoroscopy Times: A Surrogate Marker of Patient Radiation Exposure - Corrected Proof</dc:title><dc:creator>David F. Penson</dc:creator><dc:identifier>10.1016/j.juro.2011.11.050</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711057089/abstract?rss=yes"><title>Re: Urologist Compliance With AUA Best Practice Guidelines for Benign Prostatic Hyperplasia in Medicare Population - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711057089/abstract?rss=yes</link><description>S. A. Strope, S. P. Elliott, C. S. Saigal, A. Smith, T. J. Wilt and J. T. Wei; Urologic Diseases in America Project   Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri</description><dc:title>Re: Urologist Compliance With AUA Best Practice Guidelines for Benign Prostatic Hyperplasia in Medicare Population - Corrected Proof</dc:title><dc:creator>David F. Penson</dc:creator><dc:identifier>10.1016/j.juro.2011.11.051</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711057119/abstract?rss=yes"><title>Re: Risk Factors and Outcomes of Surgical Site Infection in Children - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711057119/abstract?rss=yes</link><description>B. T. Bucher, R. M. Guth, A. M. Elward, N. A. Hamilton, P. A. Dillon, B. W. Warner and M. S. Keller   Division of Pediatric Surgery, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri</description><dc:title>Re: Risk Factors and Outcomes of Surgical Site Infection in Children - Corrected Proof</dc:title><dc:creator>Edward M. Schaeffer</dc:creator><dc:identifier>10.1016/j.juro.2011.11.054</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711057272/abstract?rss=yes"><title>Re: Current Status of Urodynamics for Evaluation of Incontinence - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711057272/abstract?rss=yes</link><description>B. M. Whittam, M. R. Kaufman and R. R. Dmochowski   Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee</description><dc:title>Re: Current Status of Urodynamics for Evaluation of Incontinence - Corrected Proof</dc:title><dc:creator>Alan J. Wein</dc:creator><dc:identifier>10.1016/j.juro.2011.11.070</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711057284/abstract?rss=yes"><title>Re: Abnormal Diurnal Rhythm of Urine Output Following Renal Transplantation: The Impact of Blood Pressure and Diuretics - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711057284/abstract?rss=yes</link><description>K. Alstrup, C. Graugaard-Jensen, S. Rittig and K. A. Jørgensen   Department of Nephrology, Aarhus University Hospital, Skejby, Denmark</description><dc:title>Re: Abnormal Diurnal Rhythm of Urine Output Following Renal Transplantation: The Impact of Blood Pressure and Diuretics - Corrected Proof</dc:title><dc:creator>Alan J. Wein</dc:creator><dc:identifier>10.1016/j.juro.2011.11.071</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711057296/abstract?rss=yes"><title>Re: Pediatric Kidney Recipients With Small Capacity, Defunctionalized Urinary Bladders Receiving Adult-Sized Kidney Without Prior Bladder Augmentation - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711057296/abstract?rss=yes</link><description>S. Alexopoulos, A. Lightner, W. Concepcion, M. Rose, K. Salcedo-Concepcion and O. Salvatierra   Department of Surgery, Stanford University, Stanford, California</description><dc:title>Re: Pediatric Kidney Recipients With Small Capacity, Defunctionalized Urinary Bladders Receiving Adult-Sized Kidney Without Prior Bladder Augmentation - Corrected Proof</dc:title><dc:creator>Alan J. Wein</dc:creator><dc:identifier>10.1016/j.juro.2011.11.072</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711058010/abstract?rss=yes"><title>CME Enrollment form/Questionnaire - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711058010/abstract?rss=yes</link><description></description><dc:title>CME Enrollment form/Questionnaire - Corrected Proof</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/j.juro.2011.12.001</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>THE JOURNAL OF UROLOGY® HOME STUDY COURSE 2012 VOLUME 187/188</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711058319/abstract?rss=yes"><title>Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711058319/abstract?rss=yes</link><description>We appreciate the 3 points made by Shteynshlyuger. We depended on the recall of the family members of probands as to whether other male family members had a history of testicular torsion. We agree that family tree analysis would be helpful in better determining the mode of inheritance if accurate knowledge of the negative history of torsion of each male family member could be ascertained. Incomplete or inaccurate recall of any family member would negatively impact the usefulness of this analysis.</description><dc:title>Corrected Proof</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/j.juro.2011.10.185</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>LETTERS TO THE EDITOR/ERRATA</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711058344/abstract?rss=yes"><title>AUA Board of Directors - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711058344/abstract?rss=yes</link><description>
   Dr. Sushil S. Lacy, Urology, PC, 5500 Pine Lake Rd., Lincoln, Nebraska 68516-3389</description><dc:title>AUA Board of Directors - Corrected Proof</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/j.juro.2011.12.017</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>NEWS AND ANNOUNCEMENTS</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711058356/abstract?rss=yes"><title>This Month in Investigative Urology - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711058356/abstract?rss=yes</link><description>To determine the accuracy of a novel 3-dimensional (3-D) transrectal ultrasound (TRUS) system for image based mapping biopsies in a prostate phantom, Ukimura et al (page 000) from Los Angeles, California tested a system (Urostation®) that is capable of registering the 3-D location of each biopsy track in the 3-D prostate volume data and performing elastic image fusion of TRUS with magnetic resonance (MR) imaging. They used 3 prostate phantoms (CIRS-053) containing 3 hypoechoic lesions to perform ultrasound (US) guided biopsy, and 3 phantoms (CIRS-066) containing 3 isoechoic but MR imaging visible lesions to perform MR fusion guided biopsy. Three targeted biopsies were performed per lesion. Each biopsy tract was injected with gadolinium based MR contrast mixed with india ink. The phantoms were then subjected to 1 mm slice MR imaging and serial step sectioning to assess the accuracy of the targeted biopsy.</description><dc:title>This Month in Investigative Urology - Corrected Proof</dc:title><dc:creator>Karl-Erik Andersson</dc:creator><dc:identifier>10.1016/j.juro.2011.12.018</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>THIS MONTH IN INVESTIGATIVE UROLOGY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS002253471105837X/abstract?rss=yes"><title>Urothelial Carcinoma In Situ of the Bladder - Corrected Proof</title><link>http://www.jurology.com/article/PIIS002253471105837X/abstract?rss=yes</link><description>Urothelial carcinoma in situ (CIS) of the bladder is defined by the World Health Organization 2004 classification book as, “a non-papillary, i.e. flat, lesion in which the surface epithelium contains cells that are cytologically malignant.” Patients typically present in the fifth or sixth decade with frequency, dysuria, nocturia, suprapubic fullness and microscopic hematuria. The diagnosis can be established by cytopathological examination of cells shed into the urine (urine cytology) and white light cystoscopy with biopsies. The cystoscopic and gross appearance is typically an erythematous flat patch, although CIS mucosa can also look completely unremarkable.</description><dc:title>Urothelial Carcinoma In Situ of the Bladder - Corrected Proof</dc:title><dc:creator>Peter A. Humphrey</dc:creator><dc:identifier>10.1016/j.juro.2011.12.020</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>PATHOLOGY PAGE</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711058381/abstract?rss=yes"><title>Cystitis Cystica and Cystitis Glandularis Causing Ureteral Obstruction - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711058381/abstract?rss=yes</link><description>A 43-year-old afebrile male presented with a complaint of left lower abdominal and scrotal pain. Leukocyte count was 14,000 cells/μl and urinalysis revealed pyuria. Ultrasound of the scrotum showed left epididymo-orchitis. The pain did not respond to antibiotics, necessitating abdominal and pelvic computerized tomography (CT) that showed left hydronephrosis and hydroureter down to the bladder where there was irregular thickening at the left posterolateral aspect of the bladder wall (). On T2-weighted magnetic resonance imaging (MRI) the site of bladder wall thickening was minimally more intense than the adjacent normal bladder wall () with moderate enhancement and no involvement of the perivesical fat.</description><dc:title>Cystitis Cystica and Cystitis Glandularis Causing Ureteral Obstruction - Corrected Proof</dc:title><dc:creator>Ahsun Riaz, David D. Casalino, Daniel P. Dalton</dc:creator><dc:identifier>10.1016/j.juro.2011.12.021</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>RADIOLOGY PAGE</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711058411/abstract?rss=yes"><title>This Month in Pediatric Urology - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711058411/abstract?rss=yes</link><description>There have been several studies showing that urinary proteome profiles can identify patients with ureteropelvic junction (UPJ) obstruction. In this multi-institutional study Bandin et al (page 000) evaluate changes in the urinary proteome in children who either underwent surgical correction of UPJ or were observed without surgery and followed for 5 years. They excluded from study patients with vesicoureteral reflux, solitary kidney, bilateral hydronephrosis or any lower urinary tract anomalies. Patients not treated surgically were divided into those with mild dilatation and those described as having intermediate obstruction. These patients had SFU (Society of Fetal Urology) grade 3 or 4 hydronephrosis but normal differential renal function on diuretic renography. At the 5-year followup the urinary proteome of patients who had undergone surgical correction of the UPJ obstruction was similar to that of age matched controls. In contrast, patients followed nonoperatively had an altered urinary proteome with increased secretion of urinary peptides interpreted to be a result of increased intrarenal collagen turnover. The authors postulate this finding as a sign of ongoing renal remodeling which could potentially lead to clinical problems at a later date. It is important to note that these patients were otherwise clinically similar to the surgically treated patients. Further study and long-term followup of these patients are needed to determine if this alteration of the urinary proteome will have significant clinical implications.</description><dc:title>This Month in Pediatric Urology - Corrected Proof</dc:title><dc:creator>Michael L. Ritchey</dc:creator><dc:identifier>10.1016/j.juro.2011.12.024</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>THIS MONTH IN PEDIATRIC UROLOGY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711058435/abstract?rss=yes"><title>••• - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711058435/abstract?rss=yes</link><description>To our knowledge, no test currently available predicts the response to intravesical bacillus Calmette-Guérin (BCG) after resection in patients with bladder cancer. In this prospective trial Kamat et al (page 000) from Houston, Texas examine whether fluorescent in situ hybridization (FISH) can predict therapy failure. In 26 patients with a median followup of 24 months a third had recurrent tumors and 14% had disease progression. Patients who had a positive FISH test during BCG therapy were 3 to 5 times more likely than those who had a negative FISH test to have recurrent tumors and 5 to 13 times more likely to experience disease progression. Thus, FISH appears to be able to identify patients at higher risk for tumor recurrence and help direct alternative treatments.</description><dc:title>••• - Corrected Proof</dc:title><dc:creator>William D. Steers</dc:creator><dc:identifier>10.1016/j.juro.2011.12.026</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>THIS MONTH IN ADULT UROLOGY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534712000328/abstract?rss=yes"><title>Erratum - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534712000328/abstract?rss=yes</link><description>


   Volume 186, Number 5, Page 1938: The video is by Palminteri et al.</description><dc:title>Erratum - Corrected Proof</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/j.juro.2012.01.015</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate></item><item rdf:about="http://www.jurology.com/article/PIIS002253471200033X/abstract?rss=yes"><title>Re: Effect of Thiazides on Bone Mineral Density in Children With Idiopathic Hypercalciuria - Corrected Proof</title><link>http://www.jurology.com/article/PIIS002253471200033X/abstract?rss=yes</link><description>V. García-Nieto, M. Monge-Zamorano, M. González-García and M. I. Luis-Yanes   Pediatric Nephrology Department, Hospital Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Canary Islands, Spain</description><dc:title>Re: Effect of Thiazides on Bone Mineral Density in Children With Idiopathic Hypercalciuria - Corrected Proof</dc:title><dc:creator>Dean Assimos</dc:creator><dc:identifier>10.1016/j.juro.2012.01.016</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-23</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-23</prism:publicationDate><prism:section>UROLOGICAL SURVEY</prism:section></item><item rdf:about="http://www.jurology.com/article/PIIS0022534711054607/abstract?rss=yes"><title>Empirical Medical Therapy for Idiopathic Male Infertility: A Survey of the American Urological Association - Corrected Proof</title><link>http://www.jurology.com/article/PIIS0022534711054607/abstract?rss=yes</link><description>
Purpose: 
We determined empirical medical therapy practice patterns for idiopathic infertility.

Materials and Methods: 
We performed a survey of 7,745 practicing American Urological Association members from July to November 2010. Respondents were questioned on empirical medical therapy use, patient evaluation and selection, and preferred medications.

Results: 
A total of 387 urologists (5%) participated in the survey, of whom 16% had infertility fellowship training, two-thirds used empirical medical therapy and 78% treated with empirical medical therapy and surgery. Laboratory values important for identifying ideal candidates include sperm concentration, serum follicle-stimulating hormone and serum testosterone. The most common medications used were clomiphene citrate, human chorionic gonadotropin and anastrozole. Of respondents 25% would treat infertile males with testosterone while the patient actively pursued pregnancy. Overall 60.5% of respondents would treat with empirical therapy for 3 to 6 months. Of fellowship trained and general urologist respondents 70% and 47%, respectively, counseled patients that empirical medical therapy has unknown effects on pregnancy and sperm count.

Conclusions: 
Empirical medical therapy is used by two-thirds of survey respondents for idiopathic male infertility. There is no clear, universal pattern to the evaluation or identification of the ideal patient for such therapy among those surveyed. There is no consensus on the optimal medication and considerable ambiguity exists as to perceived effects on fertility. Of concern is that 25% of respondents use exogenous testosterone, a medication known for its contraceptive potential, for male infertility treatment. These findings confirm the need for additional studies to establish recommendations on the empirical use of medical therapy in the setting of male infertility.
</description><dc:title>Empirical Medical Therapy for Idiopathic Male Infertility: A Survey of the American Urological Association - Corrected Proof</dc:title><dc:creator>Edmund Y. Ko, Kashif Siddiqi, Robert E. Brannigan, Edmund S. Sabanegh</dc:creator><dc:identifier>10.1016/j.juro.2011.10.137</dc:identifier><dc:source>The Journal of Urology (2012)</dc:source><dc:date>2012-01-19</dc:date><prism:publicationName>The Journal of Urology</prism:publicationName><prism:publicationDate>2012-01-19</prism:publicationDate><prism:section>SEXUAL FUNCTION/INFERTILITY</prism:section></item></rdf:RDF>
